A groundbreaking medication, Retatrutide , is creating considerable buzz amongst healthcare professionals and individuals in Australia struggling with being overweight . Developed by the company , Retatrutide functions as a double GIP and GLP-1 receptor agonist, demonstrating remarkable potential to